Biological Medicine - Integrative Health Center Baku
Biological Medicine - Integrative Health Center Baku
Azerbaigian, Baku
| Azerbaigian | Turchia | Austria | |
| Trapianto di midollo osseo allogenico da donatore non correlato | - | da $80,000 | da $180,000 |
| Trapianto di midollo osseo allogenico da donatore consanguineo | - | da $65,000 | da $150,000 |
| Trapianto di midollo osseo | - | da $36,000 | da $140,000 |
| Terapia con cellule CAR-T | - | da $150,000 | da $350,000 |
| Terapia biologica | - | da $5,500 | da $20,000 |
Bookimed non aggiunge costi extra ai prezzi dei trattamenti di Ematologia Oncologia. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica al tuo arrivo nel paese.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali nei trattamenti di Ematologia Oncologia e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di trattamento di procedure di Ematologia Oncologia.
Dr. Selime Aydogdu is a specialist in pediatric hematology and oncology. She is known for her work in improving early cancer detection in children. Dr. Aydogdu has given many presentations and led discussions on recognizing early cancer symptoms. Her efforts have raised awareness in her field.
Her work has helped achieve better diagnostic results and higher survival rates for children. Dr. Aydogdu is dedicated to education and advocacy. She is a respected member of the pediatric oncology community.
I pazienti sottoposti a trattamenti ematologici e oncologici in Azerbaigian possono manifestare effetti collaterali a breve termine come perdita di capelli e affaticamento. I rischi a lungo termine includono neuropatia periferica e deficit cognitivi. Centri accreditati, come l'ospedale Liv Bona Dea di Baku o il Centro Nazionale di Oncologia, offrono supporto multidisciplinare per affrontare questi problemi.
Parere degli esperti di Bookimed: l'ospedale Liv Bona di Baku cura 200.000 pazienti all'anno ed è stato riconosciuto da Bookimed come il miglior ospedale per la cura delle malattie del sangue e del cancro nel 2019. Questo elevato volume di pazienti consente a medici specialisti come il Dott. Selim Aydogdu e il Dott. Tural Pashayev di perfezionare i protocolli di terapia di supporto per patologie complesse come la leucemia e il mieloma. I pazienti dovrebbero dare priorità alle strutture mediche accreditate JCI a Baku per garantire il rispetto degli standard di sicurezza internazionali nel trattamento delle intossicazioni.
Feedback dei pazienti: I pazienti segnalano che la stanchezza è spesso più grave del previsto e non si risolve facilmente con il riposo. Sottolineano inoltre che la neuropatia e i problemi di memoria possono persistere a lungo dopo la fine del trattamento, pertanto è fondamentale discutere di questi rischi il prima possibile.
Liv Bona Dea Hospital Baku and the National Center of Oncology are the leading facilities for haematology-oncology in Azerbaijan. These centres provide JCI-accredited care and integrated diagnostic laboratories. They specialise in treating blood cancers like leukaemia and lymphoma using immunotherapy and bone marrow transplantation.
Bookimed Expert Insight: Data shows Liv Bona Dea Hospital Baku consistently ranks as a top choice. While the National Center of Oncology has more beds, Liv Bona Dea prioritises shorter waiting times. This makes them more accessible for those travelling from abroad for urgent chemotherapy or biopsies.
Patient Consensus: Patients in Azerbaijan value hospitals that combine pathology, chemotherapy, and transfusion services. They often note that having specialist haematologists ensures clearer diagnostic staging and transparent treatment options.
Azerbaijan provides oncological care featuring bone marrow transplantation, immunotherapy, and targeted molecular therapies. JCI-accredited facilities in Baku, such as Liv Bona Dea Hospital Baku, use global protocols. Treatments include TrueBeam radiotherapy, HIPEC for abdominal cancers, and precision medicine for complex blood disorders.
Bookimed Expert Insight: Liv Bona Dea Hospital Baku serves over 200,000 patients annually. It holds specific 2019 rankings for excellence in cancer and blood disorders. This high patient volume allows the facility to maintain 219 beds and 20 specialised departments. Australian patients can expect care that includes genetic tumour profiling and molecular testing.
Patient Consensus: Patients suggest confirming local diagnostic capacity and requesting English medical reports before travel. Experience shows that Baku facilities effectively coordinate complex multi-cycle regimens. They also provide dedicated international service desks.
Recommended haematologist-oncologists in Baku for international consultations include Dr Tural Pashayev and Dr Selime Aydogdu. They practise at the JCI-accredited Liv Bona Dea Hospital. These specialists provide care for adult and paediatric blood disorders. They use modern protocols for bone marrow transplants and cell therapy.
Bookimed Expert Insight: Baku has become a regional hub for haematology-oncology. Liv Bona Dea Hospital serves over 200,000 patients annually. In 2019, it received top rankings for blood disorder treatment. This high patient volume often means the medical teams have extensive experience. They handle complex cases like bone marrow failure and rare metabolic blood diseases.
Patient Consensus: Patients find the international support teams in Azerbaijan helpful. They appreciate that major facilities coordinate digital scan uploads. These teams also handle translations for overseas medical records.
Azerbaijan provides specialised treatment for blood disorders through dedicated centres and specialist clinics in Baku. Facilities like Liv Bona Dea Hospital Baku offer bone marrow transplantation, factor therapy, and iron chelation. The country manages these conditions through national healthcare programmes and regional haematology networks.
Bookimed Expert Insight: Liv Bona Dea Hospital Baku stands out for international patients. It holds JCI accreditation. Bookimed patients ranked it as a top centre for blood disorder treatment. Public centres handle high local volume. However, this private facility integrates Turkish Medical Association standards. This makes it a preferred choice for those seeking private rooms.
Patient Consensus: Patients recommend verifying that hospitals have dedicated haematology services before travel. Those managing rare disorders emphasise confirming access to clotting factors. They also suggest coordinating care with tertiary centres in Baku.
Medical tourism for oncology in Baku is a rapidly growing regional sector. The city is a hub for haematology-oncology. It serves many patients from Central Asia and the CIS. Facilities like Liv Bona Dea Hospital Baku use Turkish medical partnerships and maintain JCI-accredited standards.
Bookimed Expert Insight: Baku has transitioned from a patient source to a regional treatment destination. Liv Bona Dea Hospital Baku now treats 200,000 patients annually across 20 departments. This volume allows the facility to provide diverse specialisations within a single centre. These range from adult haematology to paediatric cell therapy.
Patient Consensus: Patients value having access to Turkish clinical protocols in Azerbaijan. Large private hospitals in Baku are praised for their multidisciplinary approach to blood disorders and complex cancers.